Location: Home > Pharma China Web Edition
  • search
  • go
    • Industry News
    Double Crane sells equity in Beijing Fresenius 9/8/2005
    Beijing Double Crane Pharma announced in March that it agreed to sell 35% of the equity it held in Beijing Fresenius Kabi Pharma to Fresenius Kabi of Germany.  The price tag of the transaction is believed to be around RMB 200 million.
     
    Relate News
    more
  • Site map | Contact Us | Links
  • © Wicon International Group